Authors:
SJOGREN S
INGANAS M
LINDGREN A
HOLMBERG L
BERGH J
Citation: S. Sjogren et al., PROGNOSTIC AND PREDICTIVE VALUE OF C-ERBB-2 OVEREXPRESSION IN PRIMARYBREAST-CANCER, ALONE AND IN COMBINATION WITH OTHER PROGNOSTIC MARKERS, Journal of clinical oncology, 16(2), 1998, pp. 462-469
Authors:
MATTSSON JP
HERSLOF M
RYBERG B
SJOGREN S
SOLVELL L
KEELING DJ
Citation: Jp. Mattsson et al., SELECTIVE-INHIBITION OF THE AVIAN OSTEOCLAST ACID PUMP IN-VITRO INCREASES THE SELECTIVITY OF BONE-RESORPTION INHIBITION IN-VIVO, Journal of bone and mineral research, 12, 1997, pp. 246-246
Authors:
RYBERG B
HERSLOF M
IVARSSON J
KAKOLPALM D
SJOGREN S
SOLVELL L
KEELING DJ
Citation: B. Ryberg et al., EFFECT OF THE BAFILOMYCIN-RELATED COMPOUND-H-362 48 ON BONE-RESORPTION IN-VIVO/, Journal of bone and mineral research, 12, 1997, pp. 253-253
Authors:
HERSLOF M
BERGMAN R
EDVINSSON K
FREGLER C
GRANBERG K
KLINTENBERG AC
NILSSON K
RYBERG B
SJOGREN S
SOLVELL L
WU J
ORTENGREN Y
KEELING DJ
Citation: M. Herslof et al., NOVEL BAFILOMYCIN-RELATED ACID PUMP INHIBITORS AND THEIR SELECTIVITY IN-VIVO, Journal of bone and mineral research, 12, 1997, pp. 375-375
Authors:
SJOGREN S
INGANAS M
NORBERG T
LINDGREN A
NORDGREN H
HOLMBERG L
BERGH J
Citation: S. Sjogren et al., THE P53 GENE IN BREAST-CANCER - PROGNOSTIC VALUE OF COMPLEMENTARY-DNASEQUENCING VERSUS IMMUNOHISTOCHEMISTRY, Journal of the National Cancer Institute, 88(3-4), 1996, pp. 173-182
Authors:
SJOGREN S
ANDREASSON AC
RYBERG B
HERSLOF M
SOLVELL L
KEELING D
VAANANEN K
Citation: S. Sjogren et al., EFFECTS OF BAFILOMYCIN A1 ON BONE-DENSITY, STRENGTH AND MORPHOLOGY INTHE RAT, Journal of bone and mineral research, 11, 1996, pp. 400-400
Authors:
NORBERG T
JANSSON T
SJOGREN S
MARTENSSON C
ANDREASSON I
FJALLSKOG ML
LINDMAN H
NORDGREN H
LINDGREN A
HOLMBERG L
BERGH J
Citation: T. Norberg et al., OVERVIEW ON HUMAN BREAST-CANCER WITH FOCUS ON PROGNOSTIC AND PREDICTIVE FACTORS WITH SPECIAL ATTENTION ON THE TUMOR-SUPPRESSOR GENE P53, Acta oncologica, 35(5), 1996, pp. 96-102
Authors:
BERGH J
NORBERG T
SJOGREN S
LINDGREN A
HOLMBERG L
Citation: J. Bergh et al., COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY, Nature medicine, 1(10), 1995, pp. 1029-1034
Authors:
MOISES HW
YANG L
KRISTBJARNARSON H
WIESE C
BYERLEY W
MACCIARDI F
AROLT V
BLACKWOOD D
LIU X
SJOGREN S
ASCHAUER HN
HWU HG
JANG K
LIVESLEY WJ
KENNEDY JL
ZOEGA T
IVARSSON O
BUI MT
YU MH
HAVSTEEN B
COMMENGES D
WEISSENBACH J
SCHWINGER E
GOTTESMAN II
PAKSTIS AJ
WETTERBERG L
KIDD KK
HELGASON T
Citation: Hw. Moises et al., AN INTERNATIONAL 2-STAGE GENOME-WIDE SEARCH FOR SCHIZOPHRENIA SUSCEPTIBILITY GENES, Nature genetics, 11(3), 1995, pp. 321-324
Authors:
JANSSON T
INGANAS M
SJOGREN S
NORBERG T
LINDGREN A
HOLMBERG L
BERGH J
Citation: T. Jansson et al., P53 STATUS PREDICTS SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY - A NOVEL HYPOTHESIS BASED ON CLINICAL FINDINGS, Journal of clinical oncology, 13(11), 1995, pp. 2745-2751
Authors:
SJOGREN S
NILSSON AC
KEELING D
RYBERG B
WALLMARK B
Citation: S. Sjogren et al., THE EFFECTS OF S-CALCITONIN AND CLODRONATE ON AGE AND OVARIECTOMY INDUCED BONE LOSS IN THE AGED RAT, Journal of bone and mineral research, 8, 1993, pp. 190000273-190000273